Hypertonic Saline Solution Drives Neutrophil from Bystander Organ to Infectious Site in Polymicrobial Sepsis: A Cecal Ligation and Puncture Model

The effects of hypertonic saline solution (HSS) have been shown in several animal models of ischemia and shock. Literature has shown potential benefits of HSS modulating inflammatory response after sepsis in an animal model. We studied the HSS effects in sepsis through cecal ligation and puncture (CLP) in Balb-C mice. Groups studied: 1- CLP without treatment (CLP-C); 2- CLP treated with normal saline solution NaCl 0.9% – 34 ml/Kg (CLP-S); 3- CLP treated with HSS NaCl 7.5% – 4 ml/Kg (CLP-H); and 4- group (Basal) without no CLP or treatment. Volume infusion was always applied 30 min after CLP. Lung and peritoneal lavage were harvested after 6h and 24h of CLP to analyze cytokines amount, oxide nitric, lipid peroxidation and neutrophil infiltration. Neutrophil infiltration, ICAM-1, CXCR-2, and CXCL-1 in lung were reduced by HSS (CLP-H) compared to CLP-C or CLP-S. Neutrophil in peritoneal lavage was increased in 24h with HSS (CLP-H) compared to CLP and CLP-S. Peritoneal CXCR-2 was increased in CLP-C and CLP-S but presented a lower increase with HSS (CLP-H) after 6 hours. GRK-2 presented difference among the groups at 24 h, showing a profile similar to neutrophil infiltration. Pro-inflammatory cytokines (TNF-α and IL-6) were reduced by HSS treatment; CLP-S increased TNF-α. IL-10 was increased in lung tissue by the HSS treatment. The oxidative stress (TBARS and nitric oxide biochemistry markers) was reduced with HSS. Animal survival was 33.3% in CLP-C group, 46.6% in CLP-S group and 60% in the CLP-H group after the sixth day. The HSS protects the animal against sepsis. Our results suggest that the volume replacement modulate pro and anti-inflammatory mediators of an inflammatory response, but HSS presented a more effective and potent effect.

[1]  P. Henson,et al.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. , 1987, The Journal of clinical investigation.

[2]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[3]  Corinne Alberti,et al.  Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.

[4]  F. Cunha,et al.  THE ROLE OF NEUTROPHILS IN SEVERE SEPSIS , 2008, Shock.

[5]  S. Garg,et al.  Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. , 1998, Critical care medicine.

[6]  É. Szabó,et al.  Resistance to Acute Septic Peritonitis in Poly(ADP-ribose) Polymerase-1-Deficient Mice , 2002, Shock.

[7]  Jonathan Cohen,et al.  Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  D. Rittirsch,et al.  The disconnect between animal models of sepsis and human sepsis , 2007, Journal of leukocyte biology.

[9]  C. Smith,et al.  Adhesion molecules and inflammatory injury , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Hansbrough,et al.  Effects of small-volume bolus treatment with intravenous normal saline and 7.5 per cent saline in combination with 6 per cent dextran-40 on metabolic acidosis and survival in burned mice. , 1995, Burns : journal of the International Society for Burn Injuries.

[11]  T. van der Poll,et al.  Neutrophils Are Essential for Rapid Clearance of Enterococcus faecium in Mice , 2008, Infection and Immunity.

[12]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.

[13]  P. Biselli,et al.  Role of Focal Adhesion Kinase in Lung Remodeling of Endotoxemic Rats , 2012, Shock.

[14]  M. Heinzelmann,et al.  INHIBITION OF NEUTROPHIL MIGRATION AT THE SITE OF INFECTION INCREASES REMOTE ORGAN NEUTROPHIL SEQUESTRATION AND INJURY , 1997, Shock.

[15]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[16]  Jonathan Cohen.  The immunopathogenesis of sepsis , 2002, Nature.

[17]  R. Holzheimer,et al.  Intraabdominal infections: Classification, mortality, scoring and pathophysiology , 1991, Infection.

[18]  M. Malbrain,et al.  Intra-abdominal hypertension in the critically ill: it is time to pay attention. , 2005, Current opinion in critical care.

[19]  J. Sleigh,et al.  Hypertonic Fluid Administration in Patients With Septic Shock: A Prospective Randomized Controlled Pilot Study , 2012, Shock.

[20]  I. Velasco,et al.  Gene expression reprogramming protects macrophage from septic-induced cell death. , 2010, Molecular immunology.

[21]  I. Velasco,et al.  Hyperosmotic NaCl and severe hemorrhagic shock. , 1980, The American journal of physiology.

[22]  C. Werner,et al.  Effects of a single-dose hypertonic saline hydroxyethyl starch on cerebral blood flow, long-term outcome, neurogenesis, and neuronal survival after cardiac arrest and cardiopulmonary resuscitation in rats* , 2012, Critical care medicine.

[23]  T. Hartung,et al.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. , 2001 .

[24]  D. Remick,et al.  Early Enhanced Local Neutrophil Recruitment in Peritonitis-Induced Sepsis Improves Bacterial Clearance and Survival , 2010, The Journal of Immunology.

[25]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[26]  I. Velasco,et al.  Clinical review: Hypertonic saline resuscitation in sepsis , 2002, Critical care.

[27]  I. Velasco,et al.  Hypertonic saline and reduced peroxynitrite formation in experimental pancreatitis , 2011, Clinics.

[28]  I. Velasco,et al.  Hyperosmotic sodium salts reverse severe hemorrhagic shock: other solutes do not. , 1987, The American journal of physiology.

[29]  F. Soriano,et al.  Neutrophils recruitment during sepsis: Critical points and crossroads. , 2009, Frontiers in bioscience.

[30]  I. Velasco,et al.  Hypertonic and hyperoncotic resuscitation from severe hemorrhagic shock in dogs: a comparative study. , 1989, Critical care medicine.

[31]  F. Machado,et al.  Differences in Sepsis Treatment and Outcomes between Public and Private Hospitals in Brazil: A Multicenter Observational Study , 2013, PloS one.

[32]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[33]  C. Szabó,et al.  Effects of a Potent Peroxynitrite Decomposition Catalyst in Murine Models of Endotoxemia and Sepsis , 2011, Shock.

[34]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[35]  C. Szabó,et al.  Inosine improves gut permeability and vascular reactivity in endotoxic shock , 2001, Critical care medicine.

[36]  B. Levy,et al.  [The pathophysiology of septic shock]. , 2012, Soins; la revue de reference infirmiere.

[37]  J.,et al.  The New England Journal of Medicine , 2012 .

[38]  J. Vincent,et al.  Has the mortality of septic shock changed with time. , 1998, Critical care medicine.

[39]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[40]  C. Dinarello,et al.  Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.

[41]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[42]  Jianjing Xue,et al.  MAPK Signaling Drives Inflammation in LPS-Stimulated Cardiomyocytes: The Route of Crosstalk to G-Protein-Coupled Receptors , 2012, PloS one.

[43]  H. Langen,et al.  Digestion of Streptococcus pneumoniae Cell Walls with Its Major Peptidoglycan Hydrolase Releases Branched Stem Peptides Carrying Proinflammatory Activity* , 1999, The Journal of Biological Chemistry.

[44]  E. A. Bernard,et al.  Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. , 2006, American journal of respiratory and critical care medicine.